Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.
Sleep Apnea | Snoring | Oral Cancer | Oral Squamous Cell Carcinoma | Pharynx CancerEvaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 to 65
Participation Criteria
Inclusion Criteria:
* oropharyngeal cancer diagnosis
* 18 years of age and over
* female or male; ratio of 1/4 toward men
* had received RTH in the Department of Radiation Oncology,
* reporting snoring and/or respiratory cessation complaints during sleep,
Exclusion Criteria:
* pregnant or breastfeeding woman;
* edentation preventing retention of the oral appliance;
* taking opioid or anxiolitic type medications;
* history of major depression,
* uncontrolled hypertension,
* history of stroke;
* under treatment with CPAP for sleep apnea;
* regular and intense orofacial pain;
* under pharmacological treatment for insomnia;
* excessive alcohol or drug use (e.g., cannabis, opioid).
Study Location
CHUM
CHUMMontréal, Quebec
Canada
Contact Study Team
Karine Peaupert
514-890-8000- Study Sponsored By
- Centre hospitalier de l'Université de Montréal (CHUM)
- Participants Required
- More Information
- Study ID:
NCT05719779